Issue Date | Title | Involved Person(s) |
2022 | Health technology assessment (HTA) : medicines for dementia due to Alzheimer's and Parkinson's disease | Mattli, R.; Tomonaga, Y.; Tzogiou, C.; Vinci, L.; Sharakin, M., et al |
2022 | The value of prevention : a health economics perspective | Marti, Joachim; Mattli, Renato; Nicolet, Anna; Wieser, Simon |
2022 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis | Mattli, Renato; Grobet, Cécile; Sharakin, Maxim; Pöhlmann, Johannes; Vinci, Linda, et al |
2021 | The fall prevention programme 'Sicher durch den Alltag' is effective and cost-effective | Niedermann Schneider, K.; Meichtry, A.; Zindel, B.; Brunner, B.; Ernst, M., et al |
2020 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis : scoping report | Pöhlmann, Johannes; Mattli, Renato; Syleouni, Maria-Eleni; Carlander, Maria Johanna; Meier, Flurina, et al |
2020 | The burden of smoking in Switzerland : estimation for 2015 and prognosis until 2050 | Mattli, Renato; Farcher, Renato; Dettling, Marcel; Syleouni, Maria-Eleni; Wieser, Simon |